WilmerHale Advises Cue Health in $235M Private Financing to Accelerate Growth

• 6.9.2021

On May 13, 2021, Cue Health Inc., a health technology company, announced the closing of its $235 million private financing round. The investment includes participation from new investors Perceptive Advisors, MSD Capital, and Koch Strategic Platforms, a subsidiary of Koch Industries, existing investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Decheng Capital, CAVU Ventures, ACME Capital and others. Cue offers individuals and healthcare providers access to lab-quality diagnostic testing at home, at work, or at the point-of-care, all in a device that fits in the palm of your hand. The capital will be used to accelerate Cue’s growth as it pioneers a digital transformation of healthcare, beginning with diagnostics.

The WilmerHale team advising Cue Health was led by Todd Rumberger, Glenn Pollner, Dimitry Lensky and Lauren Roberts, with support from Fred Adam on tax matters, Jason Hyatt and Benn Waters on capital markets-related matters, and Heidi Treiber on securities matters.